Our log-rank test revealed that tumor diameter >40 mm, pT stage≥ 3, Fuhrman grade ≥III, and ND1 mutation were associated with worse RFS rates in patients who underwent surgery for localized RCC. This evidence concerns the gene MT-ND1 and neoplasm.